In this study, we reveal that the pharmacological inhibition of Clec7a effectively mitigates tauopathy-associated synaptic degeneration and neuroinflammatory responses in the PS19 tauopathy mouse model (Figure 3 and Figure 4). Here, CLEC7A is linked to tauopathy.